SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux.
about
Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic miceBiophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemiaEnhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null miceapoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL.Piperine inhibits ABCA1 degradation and promotes cholesterol efflux from THP-1-derived macrophages.Domains of apoE4 required for the biogenesis of apoE-containing HDL.Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis.ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCATAllele-dependent thermodynamic and structural perturbations in ApoE variants associated with the correction of dyslipidemia and formation of spherical ApoE-containing HDL particles.Discrete roles of apoA-I and apoE in the biogenesis of HDL species: lessons learned from gene transfer studies in different mouse models.Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties.Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity.Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation.HDL-mediated mechanisms of protection in cardiovascular disease.Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells.Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.Cholesterol efflux via HDL resecretion occurs when cholesterol transport out of the lysosome is impaired.The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.Novel interactomics approach identifies ABCA1 as direct target of evodiamine, which increases macrophage cholesterol efflux
P2860
Q24302828-5DE08134-F859-4C97-B5CB-DEF4AE99D956Q28477741-035A0FCD-C6FE-4866-97E1-B9FD40C58E1BQ33548671-037837F1-7CD0-4A7F-97F4-1E4E894BFE24Q33825134-3D2E105A-EB7A-4915-A488-229A887D717FQ34395184-92CF4D2A-2BD5-4060-8716-9B11B0BE0AE6Q34545047-AC564A97-AFD1-4286-8CC4-D53ED710EE1AQ35031146-FDE51ACA-9A86-4D24-A832-4A6BA6C903E8Q35897068-17632FE5-7185-42CD-ADCB-97FB78B9BE87Q36462021-A786126F-13AB-42E8-9E1D-A6237DEDCE95Q36536427-1FE4DB4D-68AC-4428-899C-D49D94651FDDQ37076007-66034698-D11E-4EB7-AD57-C91F19CDA61CQ37216782-B4E942EC-CD9C-428C-B637-9D0D023DCD94Q37597603-96A95257-2D35-47C0-8D76-1E49B5634206Q37864742-9F043583-4D16-455A-A273-B6BB614F696EQ38220762-06506302-6001-44DB-A8E1-11E488F1D7ADQ39030607-2923BB07-EDFE-4643-846A-EF52592ED6F2Q39318833-21F7F8CB-8335-4F28-BBA9-51C924FC7614Q41902903-0E3B8B55-92E2-4E1D-A8F4-EB6BE6CECD4FQ41942658-F6E06CE2-3C27-4192-80ED-8C24C0C6F7BEQ42938904-AA3B3624-36C1-4038-805E-F17EB469A772Q56341014-50447EAA-63F1-4D06-A8B1-5ABD62F24572
P2860
SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
SR-BI mediates cholesterol eff ...... I diminish cholesterol efflux.
@en
type
label
SR-BI mediates cholesterol eff ...... I diminish cholesterol efflux.
@en
prefLabel
SR-BI mediates cholesterol eff ...... I diminish cholesterol efflux.
@en
P2093
P356
P1433
P1476
SR-BI mediates cholesterol eff ...... I diminish cholesterol efflux.
@en
P2093
Angeliki Chroni
Monty Krieger
Thomas J F Nieland
P304
13132-13143
P356
10.1021/BI051029O
P407
P577
2005-10-01T00:00:00Z